Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Indole Compounds >  6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLE

6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLE

Basic information Safety Supplier Related

6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLE Basic information

Product Name:
6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLE
Synonyms:
  • 6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLE
  • 6-Amino-3,3-dimethylindolin-2-one
  • 6-Amino-1,2-dihydro-3,3-dimethyl-2-oxo-3H-indole
  • 6-Amino-3,3-dimethyl-1H-indolin-2-one
  • 6-amino-3,3-dimethyl-1H-indol-2-one
  • 2H-Indol-2-one, 6-amino-1,3-dihydro-3,3-dimethyl-
  • 6-Amino-3,3-dimethyl-1,3-dihydro-indol-2-one
  • AP3Impurity6
CAS:
100510-65-4
MF:
C10H12N2O
MW:
176.22
Mol File:
100510-65-4.mol
More
Less

6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLE Chemical Properties

Boiling point:
366.6±42.0 °C(Predicted)
Density 
1.161±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
pka
14.32±0.40(Predicted)
Appearance
Dark brown to black Solid
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
More
Less

6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLE Usage And Synthesis

Uses

6-Amino-3,3-dimethylindolin-2-one is a versatile reactant used in the preparation of selective and potent aminoisoquinoline derivatives as inhibitors of mutant B-Raf pathway. It is also used in the synthesis of pentacyclic aurora kinase inhibitors.

Synthesis

100510-64-3

100510-65-4

a) 3,3-Dimethyl-6-nitroindol-2-one (500 mg, 2.42 mmol) was dissolved in ethyl acetate (100 mL) and 10% palladium/activated carbon catalyst (129 mg, 121 μmol) was added. The reaction was stirred at 70 °C for 48 h under hydrogen atmosphere (balloon). After completion of the reaction, the catalyst was removed by filtration and the filtrate was washed with ethyl acetate. The filtrate was concentrated to give the orange powdery product 6-amino-3,3-dimethylindol-2-one (427 mg). The product was characterized by 1H NMR (DMSO-D6, 400 MHz): δ 10.75 (s, 1H), 7.92-7.89 (m, 1H), 7.62-7.58 (m, 2H), 1.30 (s, 6H).

References

[1] Patent: US2006/258689, 2006, A1. Location in patent: Page/Page column 35
[2] Patent: US4666923, 1987, A
[3] Patent: US2005/277643, 2005, A1
[4] Journal of Medicinal Chemistry, 2008, vol. 51, # 15, p. 4465 - 4475
[5] Patent: WO2014/40969, 2014, A1. Location in patent: Page/Page column 17

6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLESupplier

Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
18270980682
Email
mlcheng@sunwaypharm.cn
NovoChemy Ltd.
Tel
021-31261262/ 49 (0)17662837245
Email
sales@novochemy.com
Chengdu AstaTech Trading Co., Ltd./AstaTech (Chengdu) Pharma. Co., Ltd.
Tel
+86-28-85122536 85324413
Email
market@astatech.cn
Shanghai Hekang Biotechnology Co., Ltd.
Tel
18939837085
Email
youchemicals@gmail.com
ShangHai AmK Pharmaceutical Technology Co., Ltd.
Tel
微信 17321281695 18019252918
Email
sale@amkchem.com
More
Less

6-AMINO-3,3-DIMETHYL-2-OXO-1,3-DIHYDRO-INDOLE(100510-65-4)Related Product Information